European Archives - Page 560 of 1101 - European Medical Journal

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

First Effective Treatment of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia

Balancing risk of adverse reactions against the protection of effective vaccination is a hotly debated topic in the current phase of the global response to the COVID-19 pandemic. Rare blood clot reactions have been of particular concern, and a recently published case report shares the first successful treatment of a vaccine-induced thrombosis reaction.

Liver transplant patients with HBV-related hepatocellular carcinoma

Prof. Patrizia Burra (Italy) and Prof. Ramazan Idilman (Turkey) are sharing their experience with and knowledge about HBV-related liver transplant patients with hepatocellular carcinoma including epidemiology, risk factors for HBV recurrence and current therapy.

Talking to Lorena Kuri

Lorena Kuri, Director of Clinical Trial Diversity Strategy, BMS, discusses how to address underrepresentation in clinical trials.

Jejunojejunal Intussusception as Initial Presentation of Coeliac Disease: A Case Report and Review of Literature

Coeliac disease is a disorder of the small intestine, which is characterised by mucosal inflammation, villous atrophy, and crypt hyperplasia, and occurs upon exposure to dietary gluten; the disease…

EMJ Podcast: Advancements in the Treatment of Moderate-to-Severe Atopic Dermatitis

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the final instalment in a five-part series exploring the subject of atopic dermatitis (AD).

EMJ Podcast: The Metropolis of Marginalisation

This week, Jonathan sits down with three leaders from the charity accelerator The Voluntary Solidarity Fund (VSF) to discuss the topic of marginalisation.

EMJ Podcast: Unmet Needs Among Patients with Atherosclerotic Cardiovascular Disease Receiving Statin

This episode, sponsored by an educational grant from Amarin Corporation, is a discussion around primary prevention and treatment of atherosclerotic cardiovascular disease (ASCVD).

Talking to Rodrigo Garcia

Rodrigo Garcia, Head of Patient Centricity, Recruitment and Retention, EMD Serono, discusses the importance of diverse clinical trials.

What Factors Affect Timing of Menopause?

Combining multiple health surveys in a meta-analysis, Duke Appiah, Texas Tech University, Lubbock, Texas, USA, has produced interesting insights for the duration of a woman’s reproductive span. Lifestyle factors were analysed to show associations with the date women reach natural menopause.

Women with PCOS at High Risk for COVID-19

Domminating the statistics for infertility in women, polycystic ovary syndrome (PCOS) is the most common cause of this condition, with onset as a result of imbalanced reproductive hormones. Emerging evidence suggests a co-interaction of PCOS with infectious disease.